Pharma Outsourcing: M&A and Valuation Update

Overview

Cowen’s Pharma Outsourcing Team has prepared a short report that provides a snapshot of industry valuations and M&A activity in Pharma Outsourcing for the first quarter of 2021:

The segment is in high demand by both financial investors and strategic buyers. Despite COVID-19 and rising stock prices, we observe attractive valuations and stable sales forecasts by market participants.

With the leading Health Care equity capital markets franchise and 15 successfully completed M&A Transactions in 2020, Cowen continues to be extremely active in the Health Care sector.

Contact

Headshot DB

Dierk
Beyer

Partner
M&A, Cowen

+49 69 5060 675 62
Email

Max
Drechsel

Partner
M&A, Cowen

+49 89 1218 974 40
Email

Get Report

    Get the full report.

    Similar Insights